Evidence map›Paper›PMID 38440796›Full record

ArticleMolecular pharmaceutics2024

Use of Magnetic Resonance Imaging for Visualization of Oral Dosage Forms in the Human Stomach: A Scoping Review.

Tejal Akbar, Pavel Gershkovich, Konstantinos Stamatopoulos, Penny A Gowland, Snow Stolnik, James Butler, Luca Marciani

Abstract readScoping Review
In one paragraph

Article in Molecular pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tejal AkbarNottingham Digestive Diseases Centre and National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham NG7 2UH, U.K.ORCID 0009-0005-2910-6997
Pavel GershkovichSchool of Pharmacy, University of Nottingham, Nottingham NG7 2RD, U.K.
Konstantinos StamatopoulosDrug Product Development, GSK R&D, Ware, Hertfordshire SG12 0GX, U.K.
Penny A GowlandSir Peter Mansfield Imaging Centre, School of Physics and Astronomy, University of Nottingham, Nottingham NG7 2QX, U.K.
Snow StolnikSchool of Pharmacy, University of Nottingham, Nottingham NG7 2RD, U.K.
James ButlerDrug Product Development, GSK R&D, Ware, Hertfordshire SG12 0GX, U.K.ORCID 0000-0003-0126-967X
Luca MarcianiNottingham Digestive Diseases Centre and National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham NG7 2UH, U.K.ORCID 0000-0001-9092-4300

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral dosage forms are the most widely and frequently used formulations to deliver active pharmaceutical ingredients (APIs), due to their ease of administration and noninvasiveness. Knowledge of intragastric release rates and gastric mixing is crucial for predicting the API release profile, especially for immediate release formulations. However, knowledge of the intragastric fate of oral dosage forms

Indexed as

Gastrointestinal TractStomachAdministration, OralContrast MediaDosage FormsHumansMagnetic Resonance ImagingSolubilityTabletsContrast MediaDosage FormsTabletsdosage form disintegrationfasted stomachfed stomachin vivomagnetic resonance imagingMRIMRI contrast agentsMRI contrast markersoral dosage formsoral drug deliverystomach

Identifiers

PMID38440796
PMCPMC10988553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.